4//SEC Filing
Harshbarger Benjamin 4
Accession 0001104659-17-061561
CIK 0000827809other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:06 PM ET
Size
5.9 KB
Accession
0001104659-17-061561
Insider Transaction Report
Form 4
Harshbarger Benjamin
General Counsel and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2017-10-06+75,000→ 75,000 totalExercise: $7.03Exp: 2027-10-06→ Common Shares (75,000 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]The options shall vest and become exercisable in three equal annual installments on October 6, 2018, October 6, 2019 and October 6, 2020.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001653133
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 4:06 PM ET
- Size
- 5.9 KB